Treatment-induced adaptive immunosuppression in EGFR-mutant lung cancer

Bidragets beskrivning

In this project, we will investigate how targeted therapy in lung cancer influence the tumor immune response. Cancer cells that change during treatment may affect the tumor immune response. This could have a significant impact on treatment efficacy and the development of resistance. The project utilizes new mouse models and advanced single-cell techniques to comprehensively investigate the targeted therapy -induced changes in the tumor immune response in lung cancer, and to understand in detail the role of treatment-altered cancer cells in regulating the immune response. Our ultimate goal is to develop and test new ways to treat lung cancer.
Visa mer

Startår

2025

Slutår

2029

Beviljade finansiering

Kari Kurppa Orcid -palvelun logo
599 271 €

Finansiär

Finlands Akademi

Typ av finansiering

Akademiprojekt

Beslutfattare

Forskningsrådet för biovetenskap, hälsa och miljö
16.06.2025

Övriga uppgifter

Finansieringsbeslutets nummer

370023

Vetenskapsområden

Biomedicinska vetenskaper

Forskningsområden

Biolääketieteet